Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis
ClinicalTrials.gov · NCT03144713 · Registry updated: 2018-09-05
- Condition / research focus
- Cirrhosis
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Countries with listed sites
- India
- Registry dates and results
- Start: 2017-05-28. Completion: 2018-04-30 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Terlipressin (drug)
- Midodrine (drug)
- Albumin (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Institute of Liver and Biliary SciencesNew Delhi, National Capital Territory of Delhi, India